CTLA4Ig Can Induce T Lymphocytes Anergy to Oxidized Low Density Lipoprotein
XIAO Yun-ling,GAO Hai-qing,LIU Xiang-qun,ZHANG Jian-hua,Zhang Cai
DOI: https://doi.org/10.3969/j.issn.1673-713x.2007.01.010
2007-01-01
Abstract:Objective To investigate the effect of CTLA4Ig on oxidized low density lipoprotein (ox-LDL) induced T lymphocyte-specific immune reaction. Methods Monocytes were separated from the peripheral blood of healthy adults and cultured with rhGM-CSF 500 IU/ml and rhIL-4 500 IU/ml for 6 days to form dentritic cells (DC). Then 1×106 of the cells were harvested to analyze the expression of CD14 by flow cytometry (FCM). The other cells were treated with LPS (30 ng/ml, LPS group), LDL (10 μg/ml, LDL group), ox-LDL (10 μg/ml, ox-LDL group), or PBS in the same volume (control group) respectively for 48 hours. The rates of positive expression of CD86 and HLA-DR and their mean fluorescence intensity (MFI) were detected by FCM. The treated DC were mixed with allogeneic T lymphocytes at ratios of 1:5 and 1:10, and cultured for another 4 days. In the ox-LDL group, the DC that were mixed with allogeneic T lymphocytes at a ratio of 1:5 were subdivided into 4 groups, treated with CTLA4Ig of different concentrations (0, 1.25, 0.62, and 0.31 μg/ml, respectively). The proliferation of T lymphocytes was analyzed by MTT method, and the result was expressed as stimulation index (SI). Results The rate of positive expression of CD14 was 2.9%. In the LPS and ox-LDL groups, the rates of positive expression of CD86 and HLA-DR (96.0%±8.8% and 97.7%±11.4% for CD86, and 90.3%±8.8% and 90.9%±7.0% for HLA-DR) were significantly higher than those in the LDL group (90.0%±10.0% for CD86, and 84.4%±9.6% for H2A-DR, P0.05) and control group (87.3%±8.4% for CD86, and 83.6%±7.0% for H2A-DR, P0.05). The MFI of CD86 and HLA-DR in the ox-LDL group (73.4±6.6 and 87.0±7.1) was significantly higher than those in the LDL (40.0±7.4, P0.01; 55.0±7.7, P0.05) and control groups (54.6±8.2, P0.01; 70.2±6.7, P0.05). The SI (DC:T=1:5) elicited by DC treated with PBS, LDL, ox-LDL, and LPS were 1.32±0.23, 1.42±0.29, 1.67±0.32, and 1.75±0.32 respectively. And the SI of DC treated with ox-LDL and LPS were significantly higher than that of DC treated with PBS and LDL (P0.05). In the 3 subgroups of the ox-LDL group treated with different concentrations of CTLA4Ig, the SI were 0.96±0.30, 1.12±0.33, and 1.29±0.28, respectively, which were significantly lower than that in the subgroup treated without CTLA4Ig (1.64±0.37; P0.01, P0.01, and P0.05, respectively). Conclusion CTLA4Ig can inhibit the ox-LDL induced allogeneic mixed lymphocyte reaction, and induce T lymphocytes anergy to ox-LDL in a dose-dependent manner.